The Company has 767,705,537 ordinary fully paid shares in issue and nil non voting shares. Non voting shares are exercisable into voting shares on a 1:1 basis
The number of ordinary shares not in public hands amount to 6,666,691 equivalent to 0.9% of the issued allotted and fully paid ordinary shares.
This is correct as of 20 June 2022
|
Share Options |
|||
|
Exercise price (£) |
Number of share options exercisable into ordinary shares on issue | Expiry Date | Share options as a % of issued shares |
|
0.30 0.27 0.33 0.671 |
8,125,000 10,050,000 14,655,000(2) 21,705,000(2) |
30 September 2024 6 July 2030 27 January 2031 18 January 2027 |
1.09% 1.35% 1.96% 2.91% |
|
Share Warrants(1) |
|||
|
Exercise price (£) |
Number of share warranty exercisable into non-voting shares | Expiry date | Share options as a % of issued shares |
| 0.30 | 4,803,921 | 30 September 2024 | 1.29% |
Note: (1) The share options are exercisable into ordinary shares upon exercise, whereas the warrants are convertible into non-voting shares upon exercise.
(2) Granted but not vested. The 14.655 million share options were granted to all Executive Directors, employees and certain consultants under the updated Pantheon Resources plc 2009 Discretionary Share Option Plan ("Scheme"). The granted share options are vestable in two equal tranches; 50% on 27 January 2022 and 50% upon spudding of the Company's next well in Alaska, after Talitha #A, expected to be the Theta West well.
(3) Granted but not vested. Vestable 50% on 18 January 2027 and 50% upon the intersection of either the Shelf Margin Deltaic zone or the Alkaid Anomaly in the Alkaid #2 Well
The Ordinary Shares of the Company have not been nor will they be registered under the United States Securities Act of 1933, as amended ("Securities Act"), or under the securities laws of any state of the United States or under the applicable securities laws of Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada. Accordingly, subject to certain exceptions, the Ordinary Shares may not, directly or indirectly, be offered, sold, transferred, taken up or delivered, directly or indirectly, in the United States, Australia, the Republic of South Africa, the Republic of Ireland, Japan or Canada or for the benefit of any US person (as defined in Regulation S under the Securities Act).